Results 151 to 160 of about 34,165 (229)

Macrophage phagocytosis checkpoints in DLBCL immunotherapy: an evidence-maturity framework from CD47 to CD200. [PDF]

Front Oncol
Qi S, Deng L, Luo S, Yao Y, Chen T.
europepmc   +1 more source

Corrigendum to "CD39+CD8+ T cell infiltration is associated with clinical outcomes of subsequent immunotherapy in advanced EGFR-mutant non-small cell lung cancer". [PDF]

Ther Adv Med Oncol
europepmc   +1 more source

Beta-Globin (HBB) Mutations and Catalase Gene Polymorphisms in Beta-Thalassemia Major Patients in Al-Diwaniyah, Iraq. [PDF]

Genes (Basel)
Fairooz HA, Abdelhedi R, Khalil SH, Kharrat N, Hmani M.   +4 more
europepmc   +1 more source

BLIMP-1 and CD39 expression define human effector memory regulatory T cells in blood and recall responses to viruses. [PDF]

Immunol Cell Biol
Phetsouphanh C, Cook L, Jackson KJL, Cuff D, Klemm V, Manandhar B, Hsu DC, Xu Y, Zaunders JJ, Kelleher AD, Seddiki N.   +10 more
europepmc   +1 more source

The CD73-adenosine axis in melanoma: from multidimensional regulation to precision immunotherapy. [PDF]

Front Immunol
Liu X, Sun P, Chen C, Chen X.
europepmc   +1 more source

Indoxyl sulfate exacerbates chronic inflammation and susceptibility to severe infection via modulating T-cell CD73/adenosine signaling in chronic kidney disease. [PDF]

Ren Fail
Cao J, Nie Y, Cao X, Chen X, Bo J, Wang Y, Zou J, Ding X, Shen B, Xiang F.   +9 more
europepmc   +1 more source

Causal relationship between immune factors and Guillain-Barré syndrome: A Mendelian randomization study. [PDF]

Medicine (Baltimore)
Xu T, Zhang X, Xu X, Xiao W, Li W, Zhang X.   +5 more
europepmc   +1 more source

A distinct CAR-T cell phenotype mediates therapeutic response at limited doses. [PDF]

Nat Commun
Yousefian S, Schubert ML, Minafra AR, Derigs P, Gräßle S, Horne A, Demel UM, Liebaert J, Röthemeier C, Pupp F, Höpken UE, Krönke J, Busse A, Keller U, Schmitt A, Hübschmann D, Müller-Tidow C, Dreger P, Schmitt M, Haas S.   +19 more
europepmc   +1 more source